Product Name:

ITK-BCT


Product Number:

ab-nk274-1

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Tyrosine-protein kinase ITK/TSK

Target Alias: EMT; Lyk; PSCTK2; MGC126257; MGC126258; TLK; TSK; CCDS4336.1; ENSG00000113263

Product Type Specific: Protein kinase pan-specific antibody

Antibody Code: NK274-1

Antibody Target Type: Pan-specific

Protein UniProt: Q08881

Protein SigNET: Q08881

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human ITK sequence peptide Cat. No.: PE-01BDK85

Antibody Immunogen Sequence: CWKERPEDRPAFSRLLRQLA

Antibody Immunogen Description: Corresponds to amino acid residues C594 to A613; Pre-C-terminus

Production Method: Corresponds to amino acid residues C594 to A613; Pre-C-terminus

Antibody Modification: Protein kinase pan-specific antibody

Antibody Concentration: 0.5 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 68-72 kDa.

Scientific Background: ITK is a protein-serine/threonine kinase that is a member of the TK group of protein kinases in the Tec family. This kinase is widely distributed from moderate to high levels in most human tissues with highest expression in bladder, lung, lymph node, spleen, stomach, thymus, tonsils and uterus. Ligation of CD2, TCR or CD28 induces activation and tyrosine phosphorylation of ITK at Y512. ITK is expressed in T-cells and is important for T-cell development and activation through the antigen receptor. ITK require prior activation of Lck, ZAP70 and PI3-kinase for efficient activation. ITK knockout mice show multiple effects on T cell development, cytokine production and T-helper cell differentiation. T cells that lack or express mutant versions of ITK show impaired TCR-induced actin polymerization, cell polarization and regulation of the signalling events involved in cytoskeletal reorganization. ITK has been linked with the development of gastric adenocarcinomas, melanoma (metastatic) and lymphoproliferative syndrome ebv-associated autosomal type 1 (LPSA1).